Insulins in 2002

Australian Prescriber

Volumn 25, Issue 2, 2002, Pages 29-31

  Phillips, Pat ^a  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

Author keywords

Diabetes; Metformin

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; FATTY ACID DERIVATIVE; INSULIN; INSULIN DERIVATIVE; INSULIN LISPRO; ISOPHANE INSULIN; LONG ACTING DRUG; METFORMIN; NEUTRAL INSULIN; ROSIGLITAZONE; SULFONYLUREA DERIVATIVE;

CLINICAL TRIAL; DIABETES MELLITUS; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; DRUG MECHANISM; DRUG POTENCY; HUMAN; HYPOGLYCEMIA; INSULIN TREATMENT; SHORT SURVEY; WEIGHT GAIN;

EID: 0036222199     PISSN: 03128008     EISSN: None     Source Type: Journal    
DOI: 10.18773/austprescr.2002.032     Document Type: Short Survey

References (6)

1. Insulin analogs with improved pharmacokinetic profiles
2. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
3. Current approaches to diabetes control - How good are they?
4. Health-related quality-of-life results from multinational clinical trials of insulin lispro. Assessing benefits of a new diabetes therapy
5. Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. A randomized, controlled trial